Book Of The Day: Sept. 18th Only

Only $2.99! September 18th Only! Book of The Day!

About the book

"Whether a current cancer patient or caregiver, a survivor, a researcher, an author/speaker or a physician, Sylvie's story and information is ground-breaking, exciting and essential to know.” 

Anne Brandt
President of Best Answer for Cancer Foundation

"Sylvie's book is a true winner. She discusses a groundbreaking scientific approach to understanding and treating cancer based on her father's solid scientific approach to understanding and treating cancer based on her father's solid scientific findings while also portraying her personal trials and tribulations in trying to continue her father's research and clinical work. All of this is presented while showing how the medical and scientific establishment go to almost any length to try to stop innovation and treatment with natural unpatentable remedies, so that the pharmaceutically driven status quo can be maintained."

Michael B. Schachter, MD, CNS
Director of the Schachter Center for Complementary Medicine


Book Proceeds Support Cancer Research

100% of the author's proceeds from Winning the War on Cancer will be donated to The Beljanski Foundation, a 501(c)(3) non-profit organization, to help fund anticancer research to cure cancer the natural way.

Help spread the word by commenting, sharing, and liking this message on your social media!

Questions? We are here to answer them.

anti-cancer plants publication

The Beljanski Foundation Fall Newsletter

Anti-Cancer Plants: Scientists Confirm!

This year again scientists from all over the world have taken an interest in the natural extracts developed by Dr. Mirko Beljanski. Three new studies refer to his work, and confirm the anti-cancer activity of the plants he studied, all in extremely different areas. A new study confirms the Pao pereira (Pau pereira) extract inhibits chronic prostate inflammation. The prostate tends to enlarge and cause  potentially serious urinary problems. This condition is called BPH (Benign Prostate Hyperplasia). Millions of men suffer from it, and conventional medicine does not offer a definitive cure without side effects.

The study was conducted at Nanjing University (1), and carried out with the support of The Beljanski Foundation and CIRIS, using extracts offered by Maison Beljanski/Natural Source. It shows that Pao pereira (Pau pereira) inhibits excess NFKB activity, helping to reduce the production of inflammatory cytokines. In addition, Pao pereira (Pau pereira) induces apoptosis, also known as the ”cell death program”, of the epithelial cells and stromal cells which are inflamed. This study complements previous publications showing that Pao pereira (Pau pereira) is effective on prostate cancer cells (2), and even on metastasized cancer cells that no longer respond to hormonal treatments (3).

All of these publications on the prostate therefore confirm that thanks to its multiple mechanisms of action, Pao pereira (Pau pereira) is effective at all stages of prostate disease (inflammation, cancer, advanced cancer), without toxicity and without side effects.

Another study investigates the inhibition of colorectal cancer cells by the Pao pereira (Pau pereira) extract (4). The authors of the study first note the lack of effectiveness of conventional therapies in colorectal cancer, which they attribute in part to the fact that chemotherapy and radiotherapy induce a mutation and destruction of the p53 protein (5). P53 is essential because it is involved in DNA/protein transcription phases, and in the expression of genes which are responsible for repairing cellular damage. Noting, on the other hand, the effectiveness already noted by Dr. Mirko Beljanski of the Pao pereira (Pau pereira) extract on the selective destruction of colorectal cancer cells without affecting healthy cells (6,7), the researchers looked at the mechanism of action of the extract. This new study confirms that the regulatory action of flavoperin (an active molecule of Pao pereira extract) promotes the expression of p53, induces apoptosis in cancer cells, while inhibiting the proliferation of cancer cells (inhibition of JAKs – STATs).

Finally, The University of Kansas Medical Center (USA) has just published a study comparing several famous teas with a new blend of green teas called ”OnkoTea®”, which is a blend of organic teas selected by Dr. Mirko Beljanski (8). Green teas have long been associated with antioxidant and anti-cancer benefits, and all teas tested showed some inhibitory effect on cancer cell lines, but OnkoTea® exhibited the best inhibitory effect. Compared to Bigelow®, Kusmi® and Lipton®, OnkoTea® had the strongest anti-cancer effect on breast, liver, bladder and melanoma cancer cells.

It therefore seems that this OnkoTea®, like Pao pereira (Pau pereira), is effective on various lines of cancer cells.

A second study, specifically targeting activity on melanoma with OnkoTea®, is underway.

Healthy Tuesdays Are Back

Virtual Fall Event Series

Healthy Tuesdays | 7 PM EST
Tuesday 9/15 - Prostate and Ovarian Cancer
Tuesday 10/13 - Breast Cancer
Tuesday 11/10 - Pancreatic Cancer
Tuesday 12/1 - Giving Tuesday
Click here to RSVP

Webinars for Healthcare Professionals

Thursday 09/17 - 4 PM EST
Thursday 09/24 - 10 AM EST
Thursday 10/01 - 2 PM EST
Thursday 10/08 - 1 PM EST
Click here to RSVP
Group Health Coaching | COVID-19 Protocols
Tuesday 09/22 - 1 PM EST
Friday 10/30 - 1 PM EST
Click here to RSVP

Coming Soon

Audiobook: Winning The War On Cancer: The Epic Journey Towards a Natural Cure.
By popular demand, this award winning book will be released as an Audiobook!

Winning The War On Cancer: The Epic Journey Towards a Natural Cure reveals a true story about natural medical research that is astonishing and compelling. A critical book to read if you know anyone with cancer.

As Annie Brandt, President of the Best Answer for Cancer Foundation said, ''Whether a current cancer
patient or caregiver, a survivor, a researcher, an author/speaker, or a physician, Sylvie’s story and information is ground-breaking, exciting, and essential to know."

Email media@beljanski.org to be added to our newsletter so you'll be the first to know when the audiobook is released.

References

  1. Dong Y, Liu J, Xue Z, et al. Pao Pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NFκB signaling. BMC Complement Med Ther. 2020;20(1):150. Published 2020 May 16. doi:10.1186/s12906-020-02943-2  (https://dx.doi.org/10.1186%2Fs12906-020-02943-2)
  2. Bemis DL, Capodice JL, Desai M, Katz AE, Buttyan R. ß-Carboline Alkaloid-Enriched Extract from the Amazonian Rain Forest Tree Pao Pereira Suppresses Prostate Cancer Cells. Journal of the Society for Integrative Oncology, 2009;7(2):59-65. doi:10.2310/7200.2009.0009  (https://pubmed.ncbi.nlm.nih.gov/19476740/)
  3. Chang C, Zhao W, Xie B, et al. Pao Pereira extract suppresses castration-resistant prostate cancer cell growth, survival and Invasion through inhibition of NFkB signaling. Integrative Cancer Therapies, 2013;13(3):249-258. doi:10.1177/1534735413510557  (https://pubmed.ncbi.nlm.nih.gov/24287876/)
  4. Li JM, Huang YC, Kuo YH, et al. Flavopereirine Suppresses the Growth of Colorectal Cancer Cells through P53 Signaling Dependence. Cancers (Basel). 2019;11(7):1034. Published 2019 Jul 22. doi:10.3390/cancers11071034  (https://dx.doi.org/10.3390%2Fcancers11071034)
  5. Skinner HD, Sandulache VC, Ow TJ, et al. TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence. Clin Cancer Res. 2012;18(1):290-300. doi:10.1158/1078-0432.CCR-11-2260  (https://pubmed.ncbi.nlm.nih.gov/22090360/)
  6. Beljanski M, Beljanski MS. Selective inhibition of in vitro synthesis of cancer DNA by alkaloids of beta-carboline class. Exp Cell Biol. 1982;50(2):79-87. doi:10.1159/000163131  (https://pubmed.ncbi.nlm.nih.gov/7075859/)
  7. Beljanski M. The anticancer agent PB-100, selective active on malignant cells, inhibits multiplication of sixteen malignant cell lines, even multidrug resistant. Genet. Mol. Biol. 2000;20:29–33. doi: 10.1590/S1415-47572000000100005  (http://dx.doi.org/10.1590/S1415-47572000000100005)
  8. Chen P, Chen Q. Effects of Different Tea Products on the Growth of Cancer Cells. EC Nutrition 14.12 (2019): 01-13  (https://www.ecronicon.com/ecnu/pdf/ECNU-14-00734.pdf)

Questions? We are here to answer them.

Prostate and Ovarian Cancer

Prostate and Ovarian Cancer Awareness Month

Prostate and Ovarian Cancer Awareness Month

The Beljanski Foundation is working to cure cancer the natural way. Here are some recent breakthroughs on both prostate and ovarian cancer.

Studies confirm that thanks to its multiple mechanisms of action, Pao pereira (Pau pereira) is effective at all stages of prostate disease (inflammation, cancer, and advanced hormone independent tumors), without toxicity and without side effects. Meanwhile, another team of researchers has found that the same Pao pereira (Pau pereira) extract is effective on ovarian cancer and even ovarian cancer stem cells.

Join Us for Virtual Healthy Tuesdays Supporting Prostate and Ovarian Cancer Research

Questions? We are here to answer them.

Pao Pereira for RNA Viruses

Pao pereira for RNA Viruses

Pao pereira for RNA Viruses

HIV, Influenza, and TMV

In his patent, ‘Antiviral Preparations’, Dr. Mirko Beljanski shows that the active compound of the Pao pereira extract inhibits human immunodeficiency virus (HIV) infection (1). The patent provides data to justify this claim from cell based assays and a human clinical trial.

The assays demonstrated that the extract reduces the ‘infectious capability’ of HIV. In the clinical trial the patients enrolled were HIV positive, but taking the Pao extract for a year reduced the viral load, restored normal T lymphocyte ratios and bolstered their immune system. None of the patients progressed to more serious immune deficiency (AIDS) and none succumbed to secondary infections of any kind. The extract itself was well tolerated and safe (2).

In an earlier patent primarily focused on anti-cancer activity, Beljanski also showed that the extract is effective against influenza virus, significantly reducing pulmonary congestion through a ‘notable inhibition of influenza virus multiplication’ (3).

And in the course of experiments with plants he found that the Pao extract inhibits replication of the tobacco mosaic virus (TMV). So Pao pereira functions as an anti-viral in plants as well as animals!

What do these viruses have in common with the Coronavirus?

HIV, influenza and TMV are all RNA viruses (as opposed to DNA viruses) and this appears to be the key to the extract's activity. By binding to and blocking replication of the RNA viral genomes the extract prevents the production of new viruses and thereby curtails infections.

It is noteworthy that Coronavirus (COVID 19), is also an RNA virus and we can speculate that the Pao pereira extract might well be active against this new virus. Of course it has yet not been possible to conduct any tests so we don't have scientific data. For now, we are left with a provocative thought: potential anti-coronavirus activity of Pao pereira is consistent with it's established activity against other RNA viruses including flu and HIV.

Data from the 'Antiviral Preparations' patent showing anti-HIV activity of the Pao pereira extract also reveals anti-inflammatory effects. Levels of pro-inflammatory cytokines TNFalpha and IL-6 were normalized in the HIV positive patients. So the extract serves as an antiviral as well as a suppressor of inflammation caused by the viral infection.

Questions? We are here to answer them.

References

  1. Patent 08/196,164 PCT/FR93/00761. Antiviral Preparations. Beljanski M. 1994.
  2. “Tolerance and Feasibility of a 12-Month Therapy Using the Antiretroviral Agent PB100 in AIDS-Related Complex Patients”. D.Donadio et al. Dtsch.Zschr.Onkol.26, 6 (1994).
  3. Patent EP0059817A1 Serpentine, alstonine and sempervirine drugs for the specific inhibition of tumurous and cancerous cells.  Beljanski M., Bugiel J., 1982.
Cancer Stem Cells

Treating Cancer Stem Cells

Pancreatic Cancer: Beljanski® Extracts Neutralize Cells that Cause Recurrence

By inhibiting cancer stem cells, capable of re-initiating cancer after remission, the Beljanski® extracts, Pao pereira and Rauwolfia vomitoria, limit the risk of recurrence. Two studies confirm this action on the stem cells of pancreatic cancer, one of the most difficult to cure.

To understand the importance of the studies discussed here, one must understand how cancer cells work. Two studies published in 2012 (1) made progress on this point. They confirmed that, in all types of cancer, not all cancer cells are created equal. Some have a more important role than others: they are in a way the masters of cancer. The researchers called them Cancer Stem Cells (CSCs). If these cells are not eliminated by treatments, the risk of recurrence after remission is greater because they can recreate cancer. However, these cells develop resistance to chemotherapy (2) and radiotherapy (3). What’s even worse, CSCs can reproduce and enrich the population of resistant cells (3).

Additionally, the effectiveness of a treatment is no longer measured only by the reduction of a tumor, but also by the elimination of these CSCs.

CSCs, Pet Peeves of Oncologists

Since 2012, CSCs have become the pet peeves of oncologists. This is why the researchers at Kansas University Medical Center (KUMC) who had previously worked with the Beljanski® extracts Pao pereira and Rauwolfia vomitoria, chose to test these extracts on cancer stem cells. They also chose one of the most difficult and undoubtedly the most dangerous cancers to treat: pancreatic cancer. They conducted in vitro studies on human cells and in vivo studies on mice, which are mandatory studies to do prior to human trials. These essays resulted in two publications in peer-reviewed scientific journals.


 

Rauwolfia Vomitoria: Beljanski's® Extract Inhibits Pancreatic CSCs

The first extract used was Rauwolfia vomitoria, an African plant whose anticancer molecules were identified and extracted by Dr. Mirko Beljanski, is available today under the name RovolV®. The study tested the Beljanski® extract of Rauwolfia vomitoria in mice with pancreatic cancer. All of the data collected throughout the study shows that Rauwolfia vomitoria inhibits pancreatic CSCs o in other words, neutralizes them. They also found that this extract did not have any negative side effects.

These results are all the more remarkable in that they contrast with the poor therapeutic results obtained by conventional treatments for pancreatic cancer, linked to resistant CSCs which promote metastasis and tumor return. The study, titled Inhibition of Pancreatic Cancer Stem Cells by Rauwolfia Vomitoria Extract, was published in December 2017 by the Oncology Reports.

This study therefore scientifically validates the numerous testimonies of patients cured of this type of cancer after having used products resulting from the research of Dr. Mirko Beljanski.

 

The Beljanski® Extract Pao Pereira Inhibits Pancreatic CSCs in vitro and in vivo

KUMC conducted a second study on pancreatic cancer, but this time with Pao pereira.

“We have studied the extract of the medicinal plant Pao pereira (Pao) for its activity against pancreatic CSCs. Pao inhibited the overall proliferation of human pancreatic cancer cell lines," said the authors in the study published in May 2018 in the Journal Integrative Cancer Therapies. As for the in vivo study titled Extract of the Medicinal Plant Pao Pereira Inhibits Pancreatic Cancer Stem-Like Cell In Vitro and In Vivo, they observed that CSCs were also inhibited in mice. Most importantly, the study showed that Pao pereira did not have any unwanted side effects.


 

Importance of Avoiding Recurrences in Pancreatic Cancer

Surprisingly enough, this information has not been taken into the mainstream scientific and medical community, even though research is now focused on eliminating CSCs. The relapse of pancreatic cancer is important: the rate of Metastatic recurrence is 70% according to the French National Society of Gastroenterology (4). In the event of recurrence, even if diagnosed quickly, the chances of recovery are limited, states the European Society for Medical Oncology (5).

Clearly, it is important to treat CSCs in the first cancer treatment. And these studies show the usefulness of recommending the two Beljanski® extracts to treat CSCs. And not just for pancreatic cancer because these extracts attack cancer cells regardless of the organ or gender, without any negative side effects!


 

Questions? We are here to answer them.

References

  1. Two studies were published on CHCs in 2012
  2. Mechanisms of resistance of cancer stem cells to chemotherapy https://www.em-consulte.com/en/article/1183496
  3. Effect of Radiation Therapy on Breast Cancer Cancer Stem Cells: Resistance, Reprogramming, and Treatments https://link.springer.com/article/10.1007/s10269-017-2699-8
  4. https://www.snfge.org/content/9-cancer-du-pancreas
  5. https://www.esmo.org/content/download/6624/115167/file/ESMO-ACF-Cancer-du-Pancreas-Guide-pour-les-Patients.pdf
Publication BPH Pao Banner

Publication on Pao pereira Reducing BPH

Publication BPH Pao Banner

May 2020 – “Pao Pereira Extract Suppresses Benign Prostatic Hyperplasia by Inhibiting Inflammation-Associated NFκB Signaling”

by Yu Dong, Jiakuan Liu, Zesheng Xue, Jingya Sun, Zhengnan Huang, Yifeng Jing, Bangmin Han, Bing Shen, Jun Yan and Ruimin Huang
BMC Complement Med Ther 20, 150 (2020). https://doi.org/10.1186/s12906-020-02943-2

Nanjing_University

Pao pereira extract reduces inflammation in BPH by inhibiting NFKappaB signaling.

Pao pereira (Pau pereira) is incredibly effective for chronic inflammation of the prostate commonly known as BPH or Benign Prostatic Hyperplasia. BPH is an enlargement of the prostate caused by inflammation that is common among older men. The enlarged prostate gives rise to serious urinary problems and quality of life issues.   

A new study from Dr. Jun Yan’s group at Nanjing University in China shows that Pao pereira (Pau pereira) inhibits the control center that is activated in prostate inflammation. In BPH, this master switch, called NFKappaB, is turned on which triggers expression of pro-inflammatory cytokines and genes involved in extracellular matrix remodeling. These cytokines trigger proliferation of prostate cells and further enlargement of the gland. The Pao pereira (Pau pereira) extract turns the switch off so NFKappaB signaling is quieted and the levels of cytokines and remodelers are diminished.

Not only does the extract resolve the inflammatory response in BPH it also reduces viability of the two major cell types in the prostate: epithelial and stromal cells. The chronic inflammation associated with BPH damages and destabilizes the DNA in the cells which renders them susceptible to apoptosis induced by the Pao pereira (Pau pereira) extract.  Apoptosis, or programmed cell death, is triggered in both epithelial and stromal cells in the BPH tissue.

Induction of apoptosis is the precise mechanism of action of the Pao extract in cancer cells which, as Dr. Beljanksi showed, contain destabilized DNA. Malins’ work revealed that cells in the BPH prostate suffer similar DNA damage even though the cells are not cancerous, but rather chronically inflamed or precancerous. The new study from Dr. Yan’s group shows that DNA damage in BPH is sufficient to result in apoptosis in the presence of the Pao pereira (Pau pereira) extract.

There is more!

A previous paper from the Nanjing group showed that Pao pereira (Pau pereira) addresses the androgen imbalance that promotes BPH as men age (read the previous study from the Nanjing group here). The extract inhibits the enzyme that converts testosterone to dihydrotestosterone which triggers prostate enlargement. The Pao extract reduces the size of BPH prostates, lowers the levels of androgen receptor, and lowers PSA–the well-known marker for prostate inflammation. The Pao extract does all of this just as well Finasteride, but without the negative side effects associated with this drug.

Pao pereira (Pau pereira) is indeed incredibly effective for BPH.

Abstract

BPH Publication May 2020

Background

Our previous study revealed the extract from the bark of an Amazonian tree Pao pereira (Pau pereira) can suppress benign prostatic hyperplasia (BPH) in a rat model. Herein, we examined its inhibitory effects on human BPH cells and dissect its molecular mechanism.

Methods

We applied the Pao extract to human BPH epithelial BPH-1 and prostate myofibroblast WPMY-1 cells. Cell viability, apoptosis and immunoblotting were performed, followed by gene expression profiling and gene set enrichment analysis (GSEA) to detect the differentially expressed genes and signaling pathway induced by Pao extract. Human ex vivo BPH explant organ culture was also used to examine the effects of Pao extract on human BPH tissues.

Results

Pao extract treatment inhibited viability and induced apoptosis in human BPH-1 and WPMY-1 cells. Gene expression profiling and the following validation indicated that the expression levels of pro-apoptotic genes (eg. PCDC4, CHOP and FBXO32) were induced by Pao extract in both two cell lines. GSEA further revealed that Pao extract treatment was negatively associated with the activation of NFκB signaling. Pao extract suppressed the transcriptional activity of NFκB and down-regulated its target genes involved in inflammation (CXCL5, CXCL6 and CXCL12) and extracellular matrix (ECM) remodeling (HAS2, TNC and MMP13) in both cultured cells and human ex vivo BPH explants.

Conclusion

In both BPH epithelial and stromal cells, Pao extract induces apoptosis by upregulating the pro-apoptotic genes and inhibiting the inflammation-associated NFκB signaling via reducing phosphorylation of NFκB subunit RelA. Our data suggest that Pao extract may be a promising phytotherapeutic agent for BPH.

Research Publication Data

BPH Publication Fig 1

Figure 1 shows Pao pereira (Pau pereira) inhibited the proliferation and induced apoptosis in BPH-1 and WPMY-1 cells. Image a shows changes of BPH-1 and WPMY-1 cells upon Pao extract treated for 48 h. Image b shows the effects of Pao pereira (Pau pereira) on cell viability by the SRB assay. 

BPH Publication Fig 2

Figure 2 shows Pao pereira (Pau pereira) induced apoptosis in BPH-1 and WPMY-1 cells. Image a shows the flow cytometry analysis on BPH-1 and WPMY-1 cells treated with Pao pereira (Pau pereira) using an Annexin V-FITC/PI double staining kit. Image b shows the cell death rates in BPH-1 and WPMY-1 cells treated with Pao pereira (Pau pereira). Annexin V-positive cells were defined as apoptotic cells. Image c is the effects of Pao pereira (Pau pereira) on the apoptosis-related proteins by Western blotting assay. Data are presented as mean ± SD; * p < 0.05, ** p < 0.01, and *** p < 0.001

BPH Publication

Figure 3 shows Pao pereira (Pau pereira) inhibited NFκB signaling pathway in human BPH tissues. Image a is a schematic diagram of the ex vivo BPH explant culture process. BPH explants were treated with 0, 250, 500 μg/ml Pao pereira (Pau pereira) for 48 h. Image b is the phosphorylation of RelA and protein expression levels of pro-apoptotic and inflammation-associated genes survival-associated proteins (PDCD4 and DDIT3/CHOP) were analyzed by Western blotting in BPH explants with Pao pereira (Pau pereira) treatment. Image c is the mRNA expression levels of target genes from NFκB signaling pathway, pro-apoptotic and inflammation-associated genes in BPH explants with Pao pereira (Pau pereira) treatment by qRT-PCR. * p < 0.05, ** p < 0.01, *** p < 0.001, and ns p ≥ 0.05

Download Pao Pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NFκB signaling

Click here for more information about Pao pereira and prostate cancer

Contact Us

Questions about the publication? The Beljanski® Approach to Wellness? Looking for a doctor?

We are here to help you. Please fill out the form and a member of our team will be in touch as soon as possible.

Radiotherapy

Fibrosis and Cellular Deregulation

How to protect yourself from the side effects of radiotherapy

How can you protect yourself from the immediate or delayed side effects of radiotherapy, so often prescribed in conventional cancer care? This is a question Dr. Mirko Beljanski wanted to answer and carried out extensive research before succeeding in isolating a molecule from the tree called ginkgo biloba. The efficacy of Beljanski’s ginkgo biloba extract has been proven by scientific studies and confirmed by results obtained in people undergoing radiation therapy.

A question motivated Dr. Mirko Beljanski: how to protect people from side effects of conventional cancer treatment, including radiotherapy? Indeed, radiation does not only affect the areas treated, but often affects other parts of the body which do not need radiation and disrupts the functioning of cells. Even though modern radiation therapies are increasingly designed to reduce this from happening and the severity of damage it causes, fibrosis of the tissues between the area of ​​the body exposed to radiation and the targeted tumor remains a major problem, especially for head and neck cancers.

The French National Cancer Institute (INC) specifies on its website the multiple side effects of radiation are to be expected, which vary depending on the part of the body receiving treatment (brain, breast, intestine, etc.). Some of these effects appear quickly, but others appear long after treatment.

Gingko Biloba, the Only Tree to Resist the Hiroshima Bomb

In his desire to find a solution, Dr. Beljanski became interested in ginkgo biloba when he learned that six of these trees growing in Hiroshima, a few kilometers from where the atomic bomb exploded in 1945, survived the explosion and resumed their growth without genetic mutation. He speculated that the tree must contain a molecule that protects against radioactivity. After much research, he was able to isolate this molecule from the leaves of the tree, at the stage where they turn golden. This research led to a scientific publication.


 

Beljanski’s Extract of Ginkgo Biloba Protects Cells from Radiation

The Beljanski extract of Ginkgo biloba taken during and after exposure to radiation protects, prevents and even reverses - some even go so far as to say "cures" - fibrosis and restores the cellular mechanism disrupted by radiation.

Here is a testimonial from a patient explaining how fibrosis caused by radiation treatment for a breast tumor, impossible to heal despite years of treatment, was cured by this extract.

As Dr. Beljanski reported, the data showed that "radiation-induced skin fibrosis can be attenuated or even suppressed in vivo by a biological regulator" such as that found in the golden leaf extract of Ginkgo.

The mechanism of action of this extract is explained here on The Beljanski Foundation website.


 

Please Remember

Dr. Beljanski’s ginkgo biloba extract is very different from ginkgo biloba extracts found on the market, some of which are criticized today, and which mainly aim to improve blood circulation.

On the other hand, Dr. Beljanski's work has also focused on other side effects of radiation therapy that harm the immune system. Beljanski’s Pao pereira extract and the RNA fragments called ReaLBuild allow the body to effectively fight against these other side effects.


 

Questions? We are here to answer them.

Supplement Safety

Medical Experts Wanted to Discuss Supplement Safety

Medical Experts Wanted to Discuss Supplement Safety

The Beljanski Foundation, a New York based 501(C)(3) nonprofit organization, is dedicated to funding research for natural, non-toxic answers to cancer by continuing the work of accomplished French molecular biologist, Dr. Mirko Beljanski, who spent over 40 years studying the environmental impact on DNA replication and transcription. Over the years The Beljanski Foundation has sponsored research on the anti-cancer properties of plant extracts Dr. Beljanski discovered, collaborating with prestigious institutions including Columbia University and Kansas University Medical Center.

Plant extracts are marketed as dietary supplements by various companies. The Foundation’s first march of order was to approach a reputable manufacturing company and check if their extracts were able to match Dr. Beljanski’s original specifications regarding purity and strength.  The USP or the NSF labels were useless in this case, because those companies have developed methodologies to test very popular ingredients, but had no knowledge on how to test those little known plant extracts, and no interest in developing a methodology for testing. The manufacturer had to develop its own specifications and testing programs to ensure supplement safety. They were able to develop high quality products and the research programs have led to numerous publications in peer review papers showing how plant extracts can be both safe and effective

At a time the public is craving natural solutions that are effective and affordable, one would think that the manufacturer would boast his association with such prestigious research as a great marketing tool.

But it is not happening

The reason? Herb and supplement manufacturers who dare research their products can be put out of business if their research is deemed by authorities to reveal an intent of bringing to market a product that could help treat a medical condition!

One would think that there could be no serious objection to accurately informing the public about any lawful activity. After all, the First Amendment requires liberty to discuss publicly all matters of public concern. But since the enactment of the Dietary Supplement Health Safety Act in 1994, manufacturers making health-related claims or deemed to make an implied claim, or even deemed to have the intent to make a possible claim on food products, have been prosecuted.


 

Pharmaceuticals Continue to Shut Out Natural Solutions

In the meantime, it’s no surprise that pharmaceutical companies will protect their brands at all costs and decry natural solutions as quackery, even if this blanket rejection of natural treatments screams conflict of interest. The industry warns that if natural treatments are allowed to flourish, “Desperately ill patients clinging to false hope may refuse surgery or give up their medicine and die.” Meanwhile, the industry continues to treat only the symptoms — the consequences of the sickness and not the cause of sickness — while imposing even higher prices on its products.

Good News

The good news is that more and more good doctors are refusing to be turned into five-minute prescription dispensers. They recognize that medicine is a holistic, multifaceted discipline. They value nutrition, psychology, and environmental medicine as part of their medical practices. Meanwhile, patients are becoming more and more empowered and educated. In growing numbers, patients are seeking new personalized solutions to replace the old one-size-fits-all approach to medicine.

Help for You

Every time you see a conventional doctor, ask questions on prevention, nutrition, supplement safety and lifestyle. Tell your doctor that you expect him or her to take the time to get to know you and discuss your health goals.  We have a right to self-determination. You may ask your doctor what the alternatives are to conventional treatment. Your doctor should assist you with reviewing all the options that science offers. “Ignorance leads to the loss of Freedom,” as Benjamin Franklin has taught us.

As for the supplements themselves, I cannot stress enough the importance of the quality of the natural extracts being used. Obviously, only quality extracts sufficiently loaded with active ingredients will trigger results. Beware of the inconsistency in potency from one brand to another. There can be a huge difference in concentration between various extracts available on the market.

Beware also of substances only backed by unverified testimonials. Look instead for compounds where the mechanisms of actions have been studied and published in reputable scientific journals. More often than not, cheap imitators “borrow” the science made by serious companies and present the results as if obtained by their own product. Look for companies that pursue research, or who provide material used by researchers.

Look for the trademark. Serious, quality products are trademarked. The trademark should appear visibly on the label. Only one company has been authorized to use the Beljanski® trademark, and the products it sells are the same quality as the ones being used for research.

An aging population, combined with increased pollution, and global access to weapons of mass destruction in the form of pre-packaged foods and sugary drinks, have created the “perfect sickness storm.” Meanwhile, whatever their differences, healthcare systems around the world are all plagued by ever-increasing costs and long waits at hospitals for expensive conventional treatment. Some systems work better than others in terms of reimbursements, accessibility, and coverage, but they are all straining under the pressure of spiraling costs and reduced access. When our soil is depleted, our crops poisoned by chemicals, our milk pasteurized, our water contaminated, more than ever our society needs quality dietary supplements. This industry should be hailed for bringing us natural vitamins, antioxidants, probiotics, minerals, and other sources of goodness.

Questions? We are here to answer them.

covid-19 vaccine

Will The Coronavirus Go Away Without a Vaccine?

Will The Coronavirus Go Away Without a Vaccine? And What Will be the Real Price to Pay for this Vaccination?

Pandemics are nothing new. The Old Testament, in the books of Leviticus and Numbers, addresses the unclean and contagious nature of leprosy and provides details on how to quarantine lepers. In the fourteenth century, the world was ravaged by “the Black Death”, a bubonic plague that first originated from Asia and spread to the Mediterranean, to unleashed horrific devastations all over Europe. Despite lacking any advanced knowledge of microbes or theories of disease transmission, Venice’s local authorities managed to link the origin of the disease to a boat that had entered the port and devised containment measures of those who were contaminated. That was the introduction of the “quaranta”, a forty-day period of confinement, which was established at that time, as the length of time necessary to certify entrants as medically safe.

But for some weird reason, in the face of today’s pandemic we would not consider quarantining only the sick. The “modern” approach of quarantine is about confining the general population. Which of course, is unsustainable. Therefore, short of being able to confine healthy people forever, the next beloved idea is to mass treat it with vaccination.

But it’s not that easy. Back in the 80’s, at the height of the HIV pandemic, US Secretary of Health and Human Services Margaret Heckler predicted that a preventative vaccine would be ready for testing in two years. As we know, it never materialized.

In the fourteenth century, the world was ravaged by “the Black Death”

If we fail to find a vaccine for the Coronavirus (COVID-19), does it mean that the virus remains part of our lives? Not necessarily.

We’ve learned from past epidemics that as people get sick in the short term their immune system develops antibodies to fight the illness. In the long term this provides immunity for the affected population. This immunity limits person to person viral transmission. This is called “community” or herd immunity. It works but it can take years to achieve.

The fact is that the virus could remain with us for many years. In the meantime, the medical response to HIV/AIDS, for which a vaccine was never achieved, provides a framework for living with a disease may look like: The development of therapeutic treatments will help “flatten the curve” of new cases over time, and we will learn to live with the idea that the virus is “out there”. Developing new drugs for COVID-19 takes longer than getting approval for an existing drug, but the windfall for pharmaceutical companies developing new drugs is such, that there is a strong push back against the idea of considering anything old or natural (in other words, everything that cannot be patented). We will therefore wait for new drugs approval. The Federal Drug Administration is poised to speed it up by fast-tracking some approvals to treat those who get sick. The new norm for society will become continuing social distancing, as well as having a big number of our freedoms limited.

However, most experts remain confident that we will see the COVID-19 vaccine being developed in the coming months; in part because, the coronavirus does not mutate rapidly, making it a good candidate, at least on paper, for vaccination, and also because there is so much at stake financially and politically that pharmaceutical companies are under extreme pressure “to come up with something”.


 

So if we have a vaccine, will that be the end of the virus? Not necessarily.

Not all vaccines are effective. Actually, the CDC indicates that flu vaccine effectiveness has oscillated between 10-60% from 2005-2017, while systematic reviews show no beneficial effect of inactivated influenza vaccines on flu mortality.(1) Moreover, vaccines for the common flu (rhinoviruses and adenoviruses)—which, like the coronavirus, can cause cold symptoms—are known to be very difficult to develop. However, it is clear that even if a vaccine doesn’t work as well as advertised, chances are that low immunity will be considered better than no immunity. Considering the political pressure to provide the general population with a sense of security, any vaccine providing some level of immunity will be hailed as a victory against the pandemic.

Even though concerns over the need for more effective vaccines will be dismissed, a potential problem for vaccines that induce low levels of antibodies should not be ignored. A phenomenon called “antibody-dependent enhancement of disease”, is where the low level antibodies induce a more invasive spread of the virus into different cell types, actually worsening the disease. This is exactly what was seen in clinical trials when the science was abandoned for the HIV vaccine.

Research on the long term effects of not-so-effective vaccines reveal that even with 100% compliance, outbreaks would still occur because the vaccines would not provide the population with sufficient immunity to prevent epidemics.(2)


 

And the question arises as to whether there is a link between the flu vaccine and the deaths due to COVID-19.

From recent data (3), researchers are able to compare the results obtained by countries having enforced a strict lock down (like France, Ireland, Italy, Belgium and the UK), to those who have opted for a “smart lock down” (like the Netherlands, where only activities requiring close contact with clients, as well as bars and restaurants, were ordered to close down), to those who opted for no lock down at all, only social distancing (Sweden), it is becoming increasingly clear that the lock down has failed to translate into a reduced mortality rate of COVID-19.

Sweden and Ireland have had similar mortality rates as a result of COVID-19, while the former allowed commercial activities to continue and the latter imposed strict containment. On the other hand, Eastern Europe is much less affected than Western countries, including the United States. This can be explained by the fact that the countries of Western Europe and the United States have areas of urban concentration with high population densities and many international airports.

Additional differences like demographics (ageing and multicultural societies) and health (obesity and diabetes) can also explain why some countries have rates of less than ten per million, while Western Europe and the USA are in the hundreds.

Finally, it is important to keep in mind that all those numbers are not absolutely reliable, as significant differences in diagnostic practice and recording have been observed around the world.


 

covid19_chart_statista

There are still significant differences when comparing western countries with each other.

Belgium has the highest COVID-19 mortality rate in the world, at 763 per million, while Denmark and Germany are faring much better.

When researchers decided to compare the data with a map of the flu vaccination their findings were sobering. Pediatrician Alan Cunningham explains: “Such an observation may seem counter-intuitive, but it is possible that influenza vaccines alter our immune systems non-specifically to increase susceptibility to other infections; this has been observed with DTP and other vaccines.”(4)

It turns out that the countries with highest death rates (Belgium, Spain, Italy, UK, France, USA) had all orchestrated large vaccination campaigns specifically targeting their elderly population against the flu. Denmark and Germany, with lower use of the flu vaccine, have considerably lower COVID-19 mortality rates.

Although science should welcome data, and welcome any study shedding light to understand it meaningfully, looking at the possible correlation between the flu vaccination and the spread of the COVID-19 pandemic remains highly controversial: “Those who campaign against vaccination are campaigning against science. The science is settled…Those who have promoted the anti-vaccination myth are morally reprehensible, deeply irresponsible and have blood on their hands,” says British health secretary Matt Hancock.

 

"Settled"? When and where was the debate? Why such a dogmatic attitude?

In fact, instead of being "settled", the debate is raging! It has been shown that the onset of rheumatic disease after a number of vaccinations (including influenza, MMR, HBV, tetanus toxoid, typhoid, paratyphoid A and B (TAB), polio, diphtheria, and small pox) signifies that the vaccine may trigger persistent autoimmune response in genetically predisposed individuals, suggesting that they are at increased risk for rheumatic disease after vaccinations.(5)
In other words, vaccines can lower their immune defenses against diseases other than those covered by vaccination.
True scientific attitude presupposes an openness to the various hypotheses proposed. But conflicts of interest, the profitability of vaccination campaigns, and the political agendas of certain politicians are far more powerful levers than the scientific ethics which our "expert" lecturers seem to be entirely lacking.


 

At a minimum, intellectual honesty would be to recognize that the figures put forward by "experts" at the start of the pandemic were based on nothing.

On March 15th, as the first cases emerged, Dr. Anthony Fauci of the National Institute of Allergy & Infectious Diseases, predicted that 21 million Americans would be hospitalized with 1.7 million deaths. Three months later, less than 100,000 deaths have been reported, and this number is probably inflated, since many doctors have reported being “pressured” to classify many deaths as COVID-19, without any test being performed.(6)

No scientific evidence was needed for these terrifying numbers. Just like those hubristic economists before the 2008 global financial crisis, our health experts are now making mathematical models to fit their preconceived notions, indifferent to the economic and emotional carnage they are causing. The best we can do for now is to boost our immune system by going outside as much as possible (YES, fresh air is good for you!), enjoy the sun as much as you can (YES, Vitamin D deficiency weakens your immune system), and take two cones of RNA fragments a week (YES, they help create white blood cells and platelets, and have been shown in a clinical trial to be safe and effective even for vulnerable people under chemotherapy).(7) In my opinion is this is the best you can do to prepare your immune system to overcome anything, including any mandatory vaccination.


 

Questions? We are here to answer them.

References

Beating COVID-19

COVID-19 Testimonial

COVID-19 Testimonial: Thank you A. D. for this Testimonial About Beating the Coronavirus, Precious for the Whole Community

covid-19

Dear Team,

Five days after my 90-year-old mother had a CT scan in the hospital, she developed symptoms of the coronavirus (COVID-19). Once she became ill, my sister and I took care of her and we got infected.

We started to fight the virus without any medicine and my sister had a fever that did not give up, recurrent morning diarrhea and we both had immeasurable tiredness, until, following your answer to my email, we decided to take Pao pereira at the rate of 3 capsules 3 times a day.

We wanted to let you know that the day after the first dose, the fever and diarrhea disappeared and so did this enormous fatigue that overwhelmed us. Our condition keeps improving and 20 days after the onset of the symptoms, we can walk 30 to 40 minutes without fatigue.

Thank you for all that you do.

Best regards,

A.D.

Let's rally together to stay healthy and safe, not only during the COVID-19 pandemic, but always. We are here to help.

Pao pereira is a natural, non-toxic plant extract originally researched by Dr. Beljanski and has been helping cancer patients maintain strong immune systems for over 40 years. It has been proven to have anti-bacterial and anti-viral properties.
 
We shared this testimonial because this is what we know Pao pereira can do. Our dream is that the work of Dr. Beljanski would help so many people with ailments beyond cancer.

We are here to answer your calls. We are here to listen to what you have done to tend to illness, cancer and chronic conditions. 

Our dream is to help more people like A.D. and her family.

Dr. Beljanski

Please Help Us Do More

Please support The Beljanski Foundation. Our work is only possible thanks to your support.